| Identification | Back Directory | [Name]
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | [CAS]
1092578-48-7 | [Synonyms]
Tofacitinib-16
(3S,4R)-Tofacitinib
Tofacitinib Impurity FD+DX
YYMGYZDHOQYMFO-DGCLKSJQSA-N
Tofacitinib Impurity B(3S,4R)
Tofacitinib Impurity B (3S,4R)-Tofacitinib
(3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
(3S,4R)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3S,4R)-
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib impurity 12/(3S,4R)-Tofacitinib/3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | [Molecular Formula]
C16H20N6O | [MDL Number]
MFCD23105686 | [MOL File]
1092578-48-7.mol | [Molecular Weight]
312.37 |
| Chemical Properties | Back Directory | [density ]
1.296 | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
6.04±0.60(Predicted) |
| Hazard Information | Back Directory | [Uses]
(3S,4R)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. | [storage]
Store at -20°C |
|
|